Preparation of a Camptothecin-conjugated Molecular Carrier and its Cytotoxic Effect Toward Human Colorectal Carcinoma In Vitro
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Jeong, Dongjun | - |
dc.contributor.author | Pal, Tarun | - |
dc.contributor.author | Kim, Hyungjoo | - |
dc.contributor.author | Kim, Tae Wan | - |
dc.contributor.author | Biswas, Goutam | - |
dc.contributor.author | Lee, Daeun | - |
dc.contributor.author | Singh, Tejinder | - |
dc.contributor.author | Murthy, Akula S. N. | - |
dc.contributor.author | Kim, Wanil | - |
dc.contributor.author | Kim, Kyong-Tai | - |
dc.contributor.author | Im, Jungkyun | - |
dc.date.accessioned | 2021-08-11T11:23:58Z | - |
dc.date.available | 2021-08-11T11:23:58Z | - |
dc.date.issued | 2018-12 | - |
dc.identifier.issn | 0253-2964 | - |
dc.identifier.issn | 1229-5949 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/5456 | - |
dc.description.abstract | Camptothecin (CPT) and its derivatives are the only chemical class that targets the enzymatic activity of DNA topoisomerase I, which is involved in DNA damage and subsequent cell apoptosis. Despite CPT's advantages, its use has been restricted due to extremely poor solubility, drug resistance by several efflux pumps, short half-life, and poor bioavailability. To overcome these limitations, we designed and synthesized a water-soluble CPT-conjugated molecular transporter that successfully and rapidly delivered CPT into cells. The conjugate had affinity toward mitochondria inside cells and it was distributed mainly to kidney, lung, and spleen. MTT assay confirmed that the CPP-conjugate decreased cell viability of colon cancer cell lines to a much greater extent than the parent drug. This novel approach has the potential of improving CPT efficacy for future in vivo applications, especially for colon cancer therapy. | - |
dc.format.extent | 9 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | 대한화학회 | - |
dc.title | Preparation of a Camptothecin-conjugated Molecular Carrier and its Cytotoxic Effect Toward Human Colorectal Carcinoma In Vitro | - |
dc.type | Article | - |
dc.publisher.location | 대한민국 | - |
dc.identifier.doi | 10.1002/bkcs.11611 | - |
dc.identifier.scopusid | 2-s2.0-85057534047 | - |
dc.identifier.wosid | 000453572000008 | - |
dc.identifier.bibliographicCitation | Bulletin of the Korean Chemical Society, v.39, no.12, pp 1385 - 1393 | - |
dc.citation.title | Bulletin of the Korean Chemical Society | - |
dc.citation.volume | 39 | - |
dc.citation.number | 12 | - |
dc.citation.startPage | 1385 | - |
dc.citation.endPage | 1393 | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART002413512 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | sci | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | Chemistry | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Multidisciplinary | - |
dc.subject.keywordPlus | CELLULAR UPTAKE | - |
dc.subject.keywordPlus | SCAFFOLDS STEREOCHEMISTRY | - |
dc.subject.keywordPlus | MITOCHONDRIAL AFFINITY | - |
dc.subject.keywordPlus | ANTICANCER ACTIVITY | - |
dc.subject.keywordPlus | TRANSPORTERS | - |
dc.subject.keywordPlus | MECHANISMS | - |
dc.subject.keywordPlus | RESISTANCE | - |
dc.subject.keywordPlus | 9-NITROCAMPTOTHECIN | - |
dc.subject.keywordPlus | FORMULATIONS | - |
dc.subject.keywordPlus | DERIVATIVES | - |
dc.subject.keywordAuthor | Camptothecin | - |
dc.subject.keywordAuthor | Colorectal cancer | - |
dc.subject.keywordAuthor | Drug delivery | - |
dc.subject.keywordAuthor | Molecular carrier | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.